By Hugo Francisco de Souza Reviewed by Susha Cheriyedath, M.Sc. Oct 23 2025 A new study reveals that SARS-CoV-2 mRNA vaccines can amplify immune checkpoint therapy in lung and skin cancers by unleashing a potent interferon-driven immune surge that transforms resistant tumors into immunotherapy-ready targets. Study: SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade . Image Credit: KwangSoo Kim / Shutterstock In a recent study in the journal  Nature , researchers

Tag-uri: Coronavirus